The term “big winners” rarely comes to mind when discussing telecom stocks. That’s because of their weak, long-term performance compared to growth, real estate, and retail stocks. However, the downturn of late 2021 and 2022 has turned most telecom stocks into massive value plays. And value plays are precisely what investors are looking for in

How many stock traders can honestly say they earned a decent profit last year? Investors of Eli Lilly (NYSE:LLY) were among the few real winners, due to the share-price appreciation of LLY stock as well as the dividend payments. Moreover, there are reasons to believe Eli Lilly will maintain its outstanding track record during the coming

The boom in the technology industry came to an end in 2022. Pandemic-driven demand started to reverse. Now tech companies are cutting back expenses and laying off employees. With growth names on the decline, investors have turned to other sectors that are known for being more stable and recession-proof, such as consumer staples stocks. Consumer

Many investors understand the benefits of diversifying their portfolios. Diversification across various asset classes is a part of this discussion. Indeed, holding a certain percentage of high-growth stocks in addition to defensive dividend-paying names is a great way to build long-term wealth. There’s currently a very conspicuous shift happening in the market right now. Investors are

Now’s a great time to start considering which micro-cap stocks to buy. Generally, micro-caps are stocks with a market capitalization of less than $300 million. With a cap like that, the company doesn’t have a ton of resources – which means that it could be forced to go into debt in order to grow, or

A key to successful retirement planning or wealth building is to start early. One critical component of investing is to secure stable cash flows. This is likely through fixed income, rental income, or investment in dividend stocks. With the markets continuing to face macroeconomic headwinds, it’s a good time to look at some dividend stocks

After a rough 2022 full of geopolitical instability and skyrocketing inflation, the concept of stocks to buy for the new year may have appeared imprudent just a few weeks ago. However, the equities sector generally responded well, encouraging investors to take a shot. Fundamentally, a few notable indicators suggest it may be time for intrepid

2022 was a tough year for nearly all sectors. Tech stocks, however, were among the hardest hit as an interest-rate-driven bear market reared its ugly head.  Of course, tech stocks won’t stay beaten down forever. On the contrary, they are likely to lead the way higher during the next bull market as they have done

Renewable energy stocks represent a necessary mechanism to address environmental viability. According to NASA, the “…potential future effects of global climate change include more frequent wildfires, longer periods of drought in some regions, and an increase in the duration and intensity of tropical storms.” Still, this sector doesn’t concentrate exclusively on the science of climate

2022 was a tough year for most global equities markets. One notable exception was Latin America. The iShares Latin America 40 ETF (NYSEARCA:ILF) rose nearly 10% for the year compared with an 18% decline in the SPDR S&P 500 ETF (NYSEARCA:SPY). With some strategists forecasting 2023 will be another strong year for the region, today we’ll

Most oil and gas companies saw their stocks skyrocket in recent months. And while some have cooled off, the uncertainty of the geopolitical climate and unstable macroeconomic environment points to another year of healthy upside for energy stocks. In addition, the Federal Reserve’s commitment to a hawkish policy could also mean that purchasing power starts

Buying blue-chip stocks is generally a smart decision. They tend to be established, profitable, name-brand companies marked by reliable growth. All of these positive factors contribute to stable share prices that tend to trend upward over time.  Buying blue-chip stocks in an emerging bull market is even better. If the economy can avoid recession, then

While biotech may be the next big thing, making money through it isn’t easy. Indeed, investing in biotech stocks is often more of an art than a science. And considering these companies are solely focused on scientific endeavors, that’s not what many investors want to hear. For every Moderna (NASDAQ:MRNA), which shot to wealth and fame on